Related Experiment Video
Updated: Jan 2, 2026

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs
Published on: March 2, 2018
Neonatal Thyroid Stimulating Hormone and Subsequent Diagnosis of Autism Spectrum Disorders and Intellectual
Jennifer L Ames1, Gayle C Windham2, Kristen Lyall3
1Kaiser Permanente Division of Research, Oakland, California.
Insights
Newborn thyroid-stimulating hormone (TSH) levels were not linked to overall autism spectrum disorder (ASD) or intellectual disability risk. However, higher TSH showed a potential association with ASD involving developmental regression, warranting further investigation into thyroid hormone impacts.
Area of Science:
- Neurodevelopmental disorders
- Endocrinology
- Autism Spectrum Disorders (ASD)
Background:
- Untreated congenital hypothyroidism can lead to adverse neurodevelopmental outcomes, including intellectual disability (ID).
- The specific role of neonatal thyroid hormone insufficiency in the neurobiology of autism spectrum disorders (ASD) and its subphenotypes remains underexplored.
Purpose of the Study:
- To investigate the association between neonatal thyroid-stimulating hormone (TSH) levels and the risk of autism spectrum disorder (ASD) and intellectual disability (ID).
- To examine the relationship between neonatal TSH levels and specific ASD subphenotypes, including early-onset ASD and ASD with regression.
Main Methods:
- A population-based case-control study was conducted using data from children born in Southern California between 2000 and 2003.
- Neonatal TSH levels from routine newborn screening were analyzed for children diagnosed with ASD (n=518), ID (n=145), and general population controls (n=399).
- Multivariate logistic regression was used to calculate adjusted odds ratios (ORs) for continuous (ln-transformed) and quartile-based TSH levels.
Main Results:
- No significant association was found between continuous neonatal TSH levels and the overall risk of ASD (adj-OR: 1.00) or ID (adj-OR: 1.01).
- Among ASD subphenotypes, a suggestive inverse trend was observed between ASD with regression and neonatal TSH levels.
- This trend reached statistical significance in the highest TSH quartile for ASD with regression (adj-OR: 0.50), indicating a potential protective association.
Conclusions:
- Neonatal TSH levels do not appear to be associated with the overall risk of developing ASD or ID.
- A potential inverse association between higher neonatal TSH and ASD with regression suggests a possible role for thyroid hormones in specific ASD subtypes.
- Further research is necessary to elucidate the complex relationship between thyroid hormone function and the diverse neurobiological pathways underlying ASD subphenotypes.
Abstract:
Hypothyroid conditions in early life, if left untreated, are associated with adverse neurodevelopmental outcomes, including intellectual disability (ID). However, evidence addressing the role of neonatal thyroid hormone insufficiencies in the altered neurobiology underlying autism spectrum disorders (ASD), particularly among its subphenotypes, is limited. We conducted a population-based, case-control study among a sample of children born during 2000-2003 in Southern California. We examined neonatal thyroid-stimulating hormone (TSH) measured during routine newborn screening among children later diagnosed with ASD (n = 518) or ID (n = 145) and general population (GP) controls (n = 399). TSH was further analyzed in relation to ASD subgroups of intellectual ability and onset type (early-onset ASD vs. ASD with regression) ascertained by expert review of developmental services records. Odds ratios (ORs) of the differences in TSH between groups were obtained from multivariate logistic regression. We examined neonatal TSH as continuous (ln-transformed) and as quartiles. We found no association between continuous neonatal TSH levels and ASD (adj-OR: 1.00, 95% CI: 0.79-1.26) nor ID (adj-OR = 1.01, 95% CI: 0.73-1.40). Among ASD subphenotypes, we observed a suggestive inverse trend between ASD with regression and TSH, though the association only reached statistical significance in the highest TSH quartile (adj-OR: 0.50, 95% CI: 0.26-0.98). While there was little evidence that neonatal TSH is related to overall ASD risk, more work is needed to understand the influence of thyroid hormones on ASD subphenotypes. Autism Res 2020, 13: 444-455. © 2019 International Society for Autism Research,Wiley Periodicals, Inc. LAY SUMMARY: Low levels of thyroid hormone at birth can negatively impact brain development. We studied whether newborn levels of thyroid stimulating hormone (TSH) were associated with autism spectrum disorder (ASD) and its subtypes in a sample of children born in California. Newborn TSH was not related to the overall risk of ASD or intellectual disability. However, the relationships of thyroid hormone levels at birth and specific subtypes of ASD, particularly ASD with developmental regression, may need more research.
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Functions of Thyroid Hormones
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Intellectual Disability
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Teratogenicity

